aspirin has been researched along with tetramethylpyrazine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, J; Liu, W; Sun, Y; Wang, L; Wang, Y; Xu, C; Yu, P; Zhang, Z | 1 |
| Du, J; Sun, Y; Wang, Y; Yu, P; Zhang, G; Zhang, Z; Zhong, H | 1 |
| Gao, BT | 1 |
| Ding, YA; Yen, MH | 1 |
| Hsiao, G; Lee, YM; Sheu, JR; Yen, MH | 1 |
| Hao, Y; He, X; Sun, CC; Wang, C; Wang, K; Zhao, X | 1 |
6 other study(ies) available for aspirin and tetramethylpyrazine
| Article | Year |
|---|---|
Antioxidative and thrombolytic TMP nitrone for treatment of ischemic stroke.
Topics: Animals; Antioxidants; Brain Ischemia; Fibrinolytic Agents; Nitrogen Oxides; Pyrazines; Rats; Stroke; Thrombolytic Therapy | 2008 |
Novel multi-functional nitrones for treatment of ischemic stroke.
Topics: Animals; Dose-Response Relationship, Drug; Drug Design; Free Radical Scavengers; Male; Molecular Structure; Neurons; Neuroprotective Agents; Nitrogen Oxides; Platelet Aggregation; Rats; Rats, Sprague-Dawley; Stroke; Structure-Activity Relationship | 2012 |
[The effects of ligustrazine, aspirin and beta-histine on platelet aggregation in patients with acute ischemic stroke].
Topics: Aged; Aged, 80 and over; Aspirin; Betahistine; Cerebrovascular Disorders; Female; Fibrinolytic Agents; Humans; In Vitro Techniques; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyrazines; Pyridines; Vasodilator Agents | 1989 |
Effects of tetramethylpyrazine on platelet aggregation.
Topics: Animals; Aspirin; Collagen; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyrazines; Rats; Rats, Inbred Strains | 1987 |
Antithrombotic effects of tetramethylpyrazine in in vivo experiments.
Topics: Acute Disease; Adenosine Diphosphate; Animals; Aspirin; Bleeding Time; Blood Pressure; Drug Evaluation, Preclinical; Fibrinolytic Agents; Injections, Intravenous; Mesenteric Arteries; Mesenteric Veins; Mice; Platelet Aggregation; Platelet Aggregation Inhibitors; Pulmonary Embolism; Pyrazines; Radiation Injuries, Experimental; Reproducibility of Results; Thrombolytic Therapy; Vasodilator Agents; Venous Thrombosis | 2001 |
Simultaneous improvement of physical stability, dissolution, bioavailability, and antithrombus efficacy of Aspirin and Ligustrazine through cocrystallization.
Topics: Aspirin; Biological Availability; Crystallization; Pyrazines; Solubility | 2022 |